http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 21 May 2026 16:01:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/STAAR+Surgical+Announces+Participation+in+Upcoming+Investor+Conferences/26535008.html <p> LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences: </p><p> <b>Stifel 2026 Virtual Ophthalmology Forum <br /></b>Date: Tuesday, May 26, 2026 <br />Format: Meetings and Webcast Fireside Chat <br />Details: Investor meeting participation is by invitation only from the sponsoring brokerage firm. <br />Webcast: 4:30 PM ET, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevent.summitcast.com%2Fview%2FE3N3kijXyrec9GpoiWrbvr%2FD53AK6Xxa7fdH42DmFxruc&amp;esheet=54540481&amp;newsitemid=20260521310160&amp;lan=en-US&amp;anchor=Webcast+Link&amp;index=1&amp;md5=3ad2748c99a99c79f1e39d022b08c99e" shape="rect">Webcast Link</a> </p><p> <b>Canaccord Genuity Virtual Fireside Chat <br /></b>Date: Wednesday, May 27, 2026 <br />Format: Webcast Fireside Chat <br />Details: Registration for the webcast is by http://www.streetinsider.com/Press+Releases/STAAR+Surgical+Announces+Participation+in+Upcoming+Investor+Conferences/26535008.html Thu, 21 May 2026 16:01:00 -0400 O.00037518 STAA http://www.streetinsider.com/Press+Releases/STAAR+Surgical+Announces+Participation+in+Upcoming+Investor+Conferences/26535008.html <p> LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences: </p><p> <b>Stifel 2026 Virtual Ophthalmology Forum <br /></b>Date: Tuesday, May 26, 2026 <br />Format: Meetings and Webcast Fireside Chat <br />Details: Investor meeting participation is by invitation only from the sponsoring brokerage firm. <br />Webcast: 4:30 PM ET, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevent.summitcast.com%2Fview%2FE3N3kijXyrec9GpoiWrbvr%2FD53AK6Xxa7fdH42DmFxruc&amp;esheet=54540481&amp;newsitemid=20260521310160&amp;lan=en-US&amp;anchor=Webcast+Link&amp;index=1&amp;md5=3ad2748c99a99c79f1e39d022b08c99e" shape="rect">Webcast Link</a> </p><p> <b>Canaccord Genuity Virtual Fireside Chat <br /></b>Date: Wednesday, May 27, 2026 <br />Format: Webcast Fireside Chat <br />Details: Registration for the webcast is by http://www.streetinsider.com/Press+Releases/STAAR+Surgical+Announces+Participation+in+Upcoming+Investor+Conferences/26535008.html Thu, 21 May 2026 16:01:00 -0400 O.00037518 STAA http://www.streetinsider.com/Business+Wire/STAAR+Surgical+Announces+Participation+in+Upcoming+Investor+Conferences/26535008.html <p> LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences: </p><p> <b>Stifel 2026 Virtual Ophthalmology Forum <br /></b>Date: Tuesday, May 26, 2026 <br />Format: Meetings and Webcast Fireside Chat <br />Details: Investor meeting participation is by invitation only from the sponsoring brokerage firm. <br />Webcast: 4:30 PM ET, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevent.summitcast.com%2Fview%2FE3N3kijXyrec9GpoiWrbvr%2FD53AK6Xxa7fdH42DmFxruc&amp;esheet=54540481&amp;newsitemid=20260521310160&amp;lan=en-US&amp;anchor=Webcast+Link&amp;index=1&amp;md5=3ad2748c99a99c79f1e39d022b08c99e" shape="rect">Webcast Link</a> </p><p> <b>Canaccord Genuity Virtual Fireside Chat <br /></b>Date: Wednesday, May 27, 2026 <br />Format: Webcast Fireside Chat <br />Details: Registration for the webcast is by http://www.streetinsider.com/Business+Wire/STAAR+Surgical+Announces+Participation+in+Upcoming+Investor+Conferences/26535008.html Thu, 21 May 2026 16:01:00 -0400 O.00037518 STAA http://www.streetinsider.com/Business+Wire/STAAR+Surgical+Announces+Participation+in+Upcoming+Investor+Conferences/26535008.html <p> LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences: </p><p> <b>Stifel 2026 Virtual Ophthalmology Forum <br /></b>Date: Tuesday, May 26, 2026 <br />Format: Meetings and Webcast Fireside Chat <br />Details: Investor meeting participation is by invitation only from the sponsoring brokerage firm. <br />Webcast: 4:30 PM ET, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevent.summitcast.com%2Fview%2FE3N3kijXyrec9GpoiWrbvr%2FD53AK6Xxa7fdH42DmFxruc&amp;esheet=54540481&amp;newsitemid=20260521310160&amp;lan=en-US&amp;anchor=Webcast+Link&amp;index=1&amp;md5=3ad2748c99a99c79f1e39d022b08c99e" shape="rect">Webcast Link</a> </p><p> <b>Canaccord Genuity Virtual Fireside Chat <br /></b>Date: Wednesday, May 27, 2026 <br />Format: Webcast Fireside Chat <br />Details: Registration for the webcast is by http://www.streetinsider.com/Business+Wire/STAAR+Surgical+Announces+Participation+in+Upcoming+Investor+Conferences/26535008.html Thu, 21 May 2026 16:01:00 -0400 O.00037518 STAA http://www.streetinsider.com/Investing/STAAR+Surgical+signals+standalone+strength+as+Alcon+overhang+fades+after+strong+Q1/26527775.html <p data-path-to-node="10">Investing.com -- After one of the most contentious proxy battles in recent medical-device history, <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">STAAR Surgical</span></span> Company (NASDAQ:STAA) is beginning to prove that its standalone strategy can work. Last week, the Lake Forest-based leader in lens-based refractive surgery reported first-quarter financial results that came in well ahead of Wall Street expectations.</p> <p data-path-to-node="11">The corporate milestone signals a strong operational turnaround just months after shareholders blocked a proposed acquisition by industry giant Alcon. The return to stability has already been rewarded by public markets, pushing the stock price to $33 by May 18, 2026, comfortably above Alcon’s final sweetened http://www.streetinsider.com/Investing/STAAR+Surgical+signals+standalone+strength+as+Alcon+overhang+fades+after+strong+Q1/26527775.html Wed, 20 May 2026 15:10:39 -0400 STAA http://www.streetinsider.com/General+News/STAAR+Surgical+signals+standalone+strength+as+Alcon+overhang+fades+after+strong+Q1/26527775.html <p data-path-to-node="10">Investing.com -- After one of the most contentious proxy battles in recent medical-device history, <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">STAAR Surgical</span></span> Company (NASDAQ:STAA) is beginning to prove that its standalone strategy can work. Last week, the Lake Forest-based leader in lens-based refractive surgery reported first-quarter financial results that came in well ahead of Wall Street expectations.</p> <p data-path-to-node="11">The corporate milestone signals a strong operational turnaround just months after shareholders blocked a proposed acquisition by industry giant Alcon. The return to stability has already been rewarded by public markets, pushing the stock price to $33 by May 18, 2026, comfortably above Alcon’s final sweetened http://www.streetinsider.com/General+News/STAAR+Surgical+signals+standalone+strength+as+Alcon+overhang+fades+after+strong+Q1/26527775.html Wed, 20 May 2026 15:10:39 -0400 STAA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+Foust+Warren/26520864.html si-local-file:///var/storage/secattach/20260519/26520864.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+Foust+Warren/26520864.html Tue, 19 May 2026 16:01:00 -0400 O.00037518 STAA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+Foust+Warren/26520864.html si-local-file:///var/storage/secattach/20260519/26520864.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+Foust+Warren/26520864.html Tue, 19 May 2026 16:01:00 -0400 O.00037518 STAA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+ANDREWS+DEBORAH+J/26520866.html si-local-file:///var/storage/secattach/20260519/26520866.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+ANDREWS+DEBORAH+J/26520866.html Tue, 19 May 2026 16:01:00 -0400 O.00037518 STAA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+ANDREWS+DEBORAH+J/26520866.html si-local-file:///var/storage/secattach/20260519/26520866.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+ANDREWS+DEBORAH+J/26520866.html Tue, 19 May 2026 16:01:00 -0400 O.00037518 STAA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+Michna+Magda/26520867.html si-local-file:///var/storage/secattach/20260519/26520867.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+Michna+Magda/26520867.html Tue, 19 May 2026 16:01:00 -0400 O.00037518 STAA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+Michna+Magda/26520867.html si-local-file:///var/storage/secattach/20260519/26520867.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++STAAR+SURGICAL+CO+++++++++For%3A+May+15++Filed+by%3A+Michna+Magda/26520867.html Tue, 19 May 2026 16:01:00 -0400 O.00037518 STAA http://www.streetinsider.com/Analyst+PT+Change/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2433+at+Piper+Sandler/26489962.html (Updated - May 14, 2026 8:27 AM EDT) <p>Piper Sandler analyst Adam C. Maeder raised the price target on STAAR Surgical (NASDAQ: STAA) to $33.00 (from $16.00) while maintaining a Neutral rating.</p><p>The analyst commented: "Big Q1 Beat W/ Improved OpEx Spend, But No Guidance; STAA reported Q1 results this evening, which was consistent with the company’s Q1 pre-announcement and beat our/Street’s expectations on both the top and bottom-line. The China business was especially strong with revenue of $47.4M (vs. Street estimates of $33.8M) driven by underlying demand with inventory levels slightly reducing during the quarter. STAA also pointed to a strong http://www.streetinsider.com/Analyst+PT+Change/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2433+at+Piper+Sandler/26489962.html Thu, 14 May 2026 08:27:32 -0400 STAA http://www.streetinsider.com/Analyst+Comments/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2433+at+Piper+Sandler/26489962.html (Updated - May 14, 2026 8:27 AM EDT) <p>Piper Sandler analyst Adam C. Maeder raised the price target on STAAR Surgical (NASDAQ: STAA) to $33.00 (from $16.00) while maintaining a Neutral rating.</p><p>The analyst commented: "Big Q1 Beat W/ Improved OpEx Spend, But No Guidance; STAA reported Q1 results this evening, which was consistent with the company’s Q1 pre-announcement and beat our/Street’s expectations on both the top and bottom-line. The China business was especially strong with revenue of $47.4M (vs. Street estimates of $33.8M) driven by underlying demand with inventory levels slightly reducing during the quarter. STAA also pointed to a strong http://www.streetinsider.com/Analyst+Comments/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2433+at+Piper+Sandler/26489962.html Thu, 14 May 2026 08:27:32 -0400 STAA http://www.streetinsider.com/Upgrades/Wedbush+Upgrades+STAAR+Surgical+%28STAA%29+to+Outperform%2C+%27China+Rebound+in+Early+Innings%27/26489683.html (Updated - May 14, 2026 7:02 AM EDT) <p>Wedbush analyst Michael Piccolo upgraded STAAR Surgical (NASDAQ: STAA) from Neutral to Outperform with a price target of $40.00.</p><p>The analyst comments "We are upgrading shares of STAA from NEUTRAL to OUTPERFORM and are raising our price target from $26 to $40 per share as 1Q'26 results gives us confidence that the company is either at or nearing an inflection point for a full China rebound. While we acknowledge that we may be http://www.streetinsider.com/Upgrades/Wedbush+Upgrades+STAAR+Surgical+%28STAA%29+to+Outperform%2C+%27China+Rebound+in+Early+Innings%27/26489683.html Thu, 14 May 2026 07:02:14 -0400 STAA http://www.streetinsider.com/Analyst+Comments/Wedbush+Upgrades+STAAR+Surgical+%28STAA%29+to+Outperform%2C+%27China+Rebound+in+Early+Innings%27/26489683.html (Updated - May 14, 2026 7:02 AM EDT) <p>Wedbush analyst Michael Piccolo upgraded STAAR Surgical (NASDAQ: STAA) from Neutral to Outperform with a price target of $40.00.</p><p>The analyst comments "We are upgrading shares of STAA from NEUTRAL to OUTPERFORM and are raising our price target from $26 to $40 per share as 1Q'26 results gives us confidence that the company is either at or nearing an inflection point for a full China rebound. While we acknowledge that we may be http://www.streetinsider.com/Analyst+Comments/Wedbush+Upgrades+STAAR+Surgical+%28STAA%29+to+Outperform%2C+%27China+Rebound+in+Early+Innings%27/26489683.html Thu, 14 May 2026 07:02:14 -0400 STAA http://www.streetinsider.com/Hot+Comments/Wedbush+Upgrades+STAAR+Surgical+%28STAA%29+to+Outperform%2C+%27China+Rebound+in+Early+Innings%27/26489683.html (Updated - May 14, 2026 7:02 AM EDT) <p>Wedbush analyst Michael Piccolo upgraded STAAR Surgical (NASDAQ: STAA) from Neutral to Outperform with a price target of $40.00.</p><p>The analyst comments "We are upgrading shares of STAA from NEUTRAL to OUTPERFORM and are raising our price target from $26 to $40 per share as 1Q'26 results gives us confidence that the company is either at or nearing an inflection point for a full China rebound. While we acknowledge that we may be http://www.streetinsider.com/Hot+Comments/Wedbush+Upgrades+STAAR+Surgical+%28STAA%29+to+Outperform%2C+%27China+Rebound+in+Early+Innings%27/26489683.html Thu, 14 May 2026 07:02:14 -0400 STAA http://www.streetinsider.com/Hot+Upgrades/Wedbush+Upgrades+STAAR+Surgical+%28STAA%29+to+Outperform%2C+%27China+Rebound+in+Early+Innings%27/26489683.html (Updated - May 14, 2026 7:02 AM EDT) <p>Wedbush analyst Michael Piccolo upgraded STAAR Surgical (NASDAQ: STAA) from Neutral to Outperform with a price target of $40.00.</p><p>The analyst comments "We are upgrading shares of STAA from NEUTRAL to OUTPERFORM and are raising our price target from $26 to $40 per share as 1Q'26 results gives us confidence that the company is either at or nearing an inflection point for a full China rebound. While we acknowledge that we may be http://www.streetinsider.com/Hot+Upgrades/Wedbush+Upgrades+STAAR+Surgical+%28STAA%29+to+Outperform%2C+%27China+Rebound+in+Early+Innings%27/26489683.html Thu, 14 May 2026 07:02:14 -0400 STAA http://www.streetinsider.com/Analyst+PT+Change/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2432+at+Canaccord/26489501.html (Updated - May 14, 2026 6:52 AM EDT) <p>Canaccord analyst John Young raised the price target on STAAR Surgical (NASDAQ: STAA) to $32.00 (from $27.00) while maintaining a Buy rating.</p><p>The analyst commented: "There was very little new information on STAA’s Q1 call relative to the company’s April preannouncement, which prompted our upgrade (see note here). Still, we believe STAA’s clean Q1 results provide a solid foundation for the rest of 2026. Because this was only one quarter of solid execution and there are still a lot of unknowns, interim management is still not providing guidance, leading us to leave our estimates http://www.streetinsider.com/Analyst+PT+Change/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2432+at+Canaccord/26489501.html Thu, 14 May 2026 06:52:46 -0400 STAA http://www.streetinsider.com/Analyst+Comments/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2432+at+Canaccord/26489501.html (Updated - May 14, 2026 6:52 AM EDT) <p>Canaccord analyst John Young raised the price target on STAAR Surgical (NASDAQ: STAA) to $32.00 (from $27.00) while maintaining a Buy rating.</p><p>The analyst commented: "There was very little new information on STAA’s Q1 call relative to the company’s April preannouncement, which prompted our upgrade (see note here). Still, we believe STAA’s clean Q1 results provide a solid foundation for the rest of 2026. Because this was only one quarter of solid execution and there are still a lot of unknowns, interim management is still not providing guidance, leading us to leave our estimates http://www.streetinsider.com/Analyst+Comments/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2432+at+Canaccord/26489501.html Thu, 14 May 2026 06:52:46 -0400 STAA http://www.streetinsider.com/Analyst+PT+Change/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2427+at+Mizuho/26489482.html Mizuho analyst Anthony Petrone raised the price target on STAAR Surgical (NASDAQ: STAA) to $27.00 (from $22.00) while maintaining a Neutral rating. http://www.streetinsider.com/Analyst+PT+Change/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2427+at+Mizuho/26489482.html Thu, 14 May 2026 06:38:16 -0400 STAA http://www.streetinsider.com/Analyst+PT+Change/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2431+at+Stifel/26488548.html <p>Stifel analyst Thomas M. Stephan raised the price target on STAAR Surgical (NASDAQ: STAA) to $31.00 (from $18.00) while maintaining a Hold rating.</p><p>The analyst comments " As pre-announced, 1Q26 revenue of $93.5M was well-above Street, as China—where end-market demand is stabilizing with ICL taking share—was a key driver. With a question following the pre-announcement, management emphasized that a China restock did not benefit results, suggesting 1Q26 was “clean/real”. • With this 1Q26 base in mind—along with positive 2Q China trends commentary pointing to sequential growth—the basic math would yield upwards of $390M-$407M in 2026 revenue… this assumes the first quarter http://www.streetinsider.com/Analyst+PT+Change/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2431+at+Stifel/26488548.html Thu, 14 May 2026 04:29:21 -0400 STAA http://www.streetinsider.com/Analyst+Comments/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2431+at+Stifel/26488548.html <p>Stifel analyst Thomas M. Stephan raised the price target on STAAR Surgical (NASDAQ: STAA) to $31.00 (from $18.00) while maintaining a Hold rating.</p><p>The analyst comments " As pre-announced, 1Q26 revenue of $93.5M was well-above Street, as China—where end-market demand is stabilizing with ICL taking share—was a key driver. With a question following the pre-announcement, management emphasized that a China restock did not benefit results, suggesting 1Q26 was “clean/real”. • With this 1Q26 base in mind—along with positive 2Q China trends commentary pointing to sequential growth—the basic math would yield upwards of $390M-$407M in 2026 revenue… this assumes the first quarter http://www.streetinsider.com/Analyst+Comments/STAAR+Surgical+%28STAA%29+PT+Raised+to+%2431+at+Stifel/26488548.html Thu, 14 May 2026 04:29:21 -0400 STAA http://www.streetinsider.com/Special+Reports/After-hours+movers%3A+CSCO%2C+HPE%2C+DOCS%2C+STUB%2C+STAA%2C+GO/26486852.html <p><strong>After-hours movers:</strong></p><p><strong>Cisco Systems </strong>(NASDAQ: CSCO) | +15%</p><p>Cisco shares surged after the company exceeded Q3 expectations for both earnings and revenue. The rally was further fueled by an optimistic outlook, with management raising its full-year 2026 guidance well above consensus estimates.</p><p><strong>Doximity, Inc. </strong>(NYSE: DOCS) | -15.0%</p><p>Doximity’s stock plummeted following a Q4 earnings miss and a disappointing forecast for its adjusted EBITDA. While revenue slightly beat expectations, the projected EBITDA of $323M to $335M fell significantly short of the $373.8M anticipated by analysts.</p><p><strong>StubHub Holdings, Inc</strong>. (NYSE: STUB) | +16.0%</p><p>StubHub shares jumped as the company swung to a Q1 profit of $0.06 per http://www.streetinsider.com/Special+Reports/After-hours+movers%3A+CSCO%2C+HPE%2C+DOCS%2C+STUB%2C+STAA%2C+GO/26486852.html Wed, 13 May 2026 16:35:10 -0400 CSCO DOCS GO HPE STAA STUB http://www.streetinsider.com/Special+Reports/After-hours+movers%3A+CSCO%2C+HPE%2C+DOCS%2C+STUB%2C+STAA%2C+GO/26486852.html <p><strong>After-hours movers:</strong></p><p><strong>Cisco Systems </strong>(NASDAQ: CSCO) | +15%</p><p>Cisco shares surged after the company exceeded Q3 expectations for both earnings and revenue. The rally was further fueled by an optimistic outlook, with management raising its full-year 2026 guidance well above consensus estimates.</p><p><strong>Doximity, Inc. </strong>(NYSE: DOCS) | -15.0%</p><p>Doximity’s stock plummeted following a Q4 earnings miss and a disappointing forecast for its adjusted EBITDA. While revenue slightly beat expectations, the projected EBITDA of $323M to $335M fell significantly short of the $373.8M anticipated by analysts.</p><p><strong>StubHub Holdings, Inc</strong>. (NYSE: STUB) | +16.0%</p><p>StubHub shares jumped as the company swung to a Q1 profit of $0.06 per http://www.streetinsider.com/Special+Reports/After-hours+movers%3A+CSCO%2C+HPE%2C+DOCS%2C+STUB%2C+STAA%2C+GO/26486852.html Wed, 13 May 2026 16:35:10 -0400 CSCO DOCS GO HPE STAA STUB